SK Biopharmaceuticals builds massive AI dataset to speed up drug discovery
SK Biopharmaceuticals, a Korean firm focused on developing original prescription drugs, has built a massive artificial intelligence (AI) dataset of more than 7 million chemical entries to streamline candidate screening for new therapies. The project is part of the Ministry of Science and ICT’s program to develop AI foundation models for specific fields. A foundation model is a large AI model…
Read original article on Korea Times News →Related news
-
3 charged in scheme to use AI to impersonate CEOs, attorneys to steal $129 mil.
Crime & Justice
Cybercrime
United States
-
Korea to see warm, wet winter due to powerful El Nino
Environment & Nature
Weather
South Korea
-
Key lessons Korea should learn from US midterm elections
International
Diplomacy
South Korea
-
4 Cornell lawsuit defendants join effort to oust Letitia James from criminal investigation
Crime & Justice
Courts
United States
-
Veterans ministry to invite foreign Korean War veterans, families on UN memorial day
International
Foreign Aid
South Korea
-
Nongshim takes Shin Ramyun food truck to northeastern India
Business
Retail
India
-
DPK leader makes public apology over Shincheonji claim amid backlash from lawmakers
Politics
Political Parties
South Korea
-
Doosan Corp. expands in China to boost supply of key materials for AI chips, smartphones
Business
Manufacturing
China